← Back to Search

Behavioral Intervention

AAC Technology for Child Hearing Loss

N/A

Recruiting

Led By Jareen Meinzen-Derr, PhD

Research Sponsored by Children's Hospital Medical Center, Cincinnati

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Currently receiving speech-language therapy

Documented permanent bilateral hearing loss with severity levels clinically defined in any range (mild to profound)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change between baseline and 24 weeks

Awards & highlights

Study Summary

This trial will test whether AAC technology can help improve language development in deaf or hard of hearing children.

Who is the study for?

This trial is for children with a language gap and documented permanent bilateral hearing loss of any severity who are already receiving speech-language therapy. It excludes those whose primary language isn't English, have significant motor impairments, nonverbal IQ below 60, or severe communication disorders like autism.Check my eligibility

What is being tested?

The study tests if using augmentative and alternative communication (AAC) technology can improve language development in deaf or hard-of-hearing children. Participants will either receive AAC tech alongside their usual speech therapy or continue with their current care without the tech.See study design

What are the potential side effects?

Since this trial involves educational technology rather than medication, traditional side effects aren't expected. However, there may be indirect effects on behavior or frustration levels due to adapting to new technologies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently undergoing speech-language therapy.

Select...

I have permanent hearing loss in both ears.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change between baseline and 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change between baseline and 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Discourse

Syntax

semantics

Secondary outcome measures

Language standard scores (receptive and expressive)

Social functioning

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Technology-assisted language interventionExperimental Treatment1 Intervention

This intervention will incorporate augmentative and alternative communication software delivered on iPads into speech-language therapy

Group II: usual careActive Control1 Intervention

This group will be usual care children are already receiving.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor

815 Previous Clinical Trials

6,531,437 Total Patients Enrolled

3 Trials studying Hearing Loss

169 Patients Enrolled for Hearing Loss

Children's Hospital ColoradoOTHER

116 Previous Clinical Trials

5,132,461 Total Patients Enrolled

Jareen Meinzen-Derr, PhDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati

Media Library

AAC Technology (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT02998164 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the uppermost cap on participants for this experiment?

"Affirmative. The information reported on clinicaltrials.gov reveals that the trial was opened for recruitment on October 1st 2016 and is currently recruiting, with its latest update being February 23rd 2021. A total of 154 participants are needed to be enrolled from two different sites."

Answered by AI

Does the research protocol for this trial encompass individuals younger than 40 years old?

"This medical trial requires all applicants to be within the 3-10 age range. Additionally, there are 60 studies for minors and 127 for those above 65 years old."

Answered by AI

Is there an opportunity for me to take part in this research endeavor?

"This hearing loss trial seeks 154 patients aged between 3 and 10 years old who have a permanent bilateral auditory deficiency, along with an associated language gap. Participants must also be receiving speech-language therapy as part of the study's criteria."

Answered by AI

Is there currently a recruitment effort for this trial?

"Affirmative. Clinicaltrials.gov documents that this research is actively enrolling participants, with the initial post dating back to October 1st 2016 and the last edit on February 23rd 2021. The trial requires 154 test subjects distributed across 2 locations."

Answered by AI

Recent research and studies

PediatricsJournal

A Technology-assisted Language Intervention for Children Who Are Deaf or Hard of Hearing: A Randomized Clinical Trial

Meinzen-Derr, Jareen, Rose Sheldon, Mekibib Altaye, Laura Lane, Lindsay Mays, and Susan Wiley. 2021. “A Technology-assisted Language Intervention for Children Who Are Deaf or Hard of Hearing: A Randomized Clinical Trial”. Pediatrics. American Academy of Pediatrics (AAP). doi:10.1542/peds.2020-025734.

clinicaltrials.govStudy

Improving Outcomes Using Technology for Children Who Are DHH

2016. "Improving Outcomes Using Technology for Children Who Are DHH". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02998164.

All > Hearing Loss